Clinical trial
A Phase III Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, Applied Once Daily for 12 Weeks in Patients With Acne Vulgaris (GEDACNE-2)
NCT07384208 is registered in ClinicalTrials.gov with PPM Services S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, Applied Once Daily for 12 Weeks in Patients With Acne Vulgaris (GEDACNE-2)
- Lead sponsor
- PPM Services S.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 19, 2024
- Completion date
- May 28, 2026
- Enrollment
- 398 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.